Cargando…

Do Nonalcoholic Fatty Liver Disease and Fetuin-A Play Different Roles in Symptomatic Coronary Artery Disease and Peripheral Arterial Disease?

Background and Aims: Nonalcoholic fatty liver disease (NAFLD) is strongly associated with both atherosclerotic cardiovascular disease (CVD) and Fetuin-A. However, the association of Fetuin-A with atherosclerosis is more controversial. We hypothesized that the pathogenic interplay of NAFLD, Fetuin-A...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nascimbeni, Fabio, Romagnoli, Dante, Ballestri, Stefano, Baldelli, Enrica, Lugari, Simonetta, Sirotti, Valentina, Giampaoli, Valentina, Lonardo, Amedeo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5871963/ https://www.ncbi.nlm.nih.gov/pubmed/29462898 http://dx.doi.org/10.3390/diseases6010017

Ejemplares similares

NAFLD as a Sexual Dimorphic Disease: Role of Gender and Reproductive Status in the Development and Progression of Nonalcoholic Fatty Liver Disease and Inherent Cardiovascular Risk
por: Ballestri, Stefano, et al.
Publicado: (2017)

Liver Fibrosis Biomarkers Accurately Exclude Advanced Fibrosis and Are Associated with Higher Cardiovascular Risk Scores in Patients with NAFLD or Viral Chronic Liver Disease
por: Ballestri, Stefano, et al.
Publicado: (2021)

Type 2 Diabetes in Non-Alcoholic Fatty Liver Disease and Hepatitis C Virus Infection—Liver: The “Musketeer” in the Spotlight
por: Ballestri, Stefano, et al.
Publicado: (2016)

Fatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIV
por: Lonardo, Amedeo, et al.
Publicado: (2016)

Alcohol and Steatosis: The Japanese Paradox
por: Lonardo, A., et al.
Publicado: (2016)

Methodological Tools for Exploring Novel Biopharmaceutical Approaches to the Metabolic Syndrome and Related Disorders: A Commentary on: Translational Research Methods in Diabetes, Obesity, and Nonalcoholic Fatty Liver Disease. A Focus on Early Phase Clinical Drug Development, Second Edition
por: Lonardo, Amedeo, et al.
Publicado: (2020)

Nonalcoholic fatty liver disease: Evolving paradigms
por: Lonardo, Amedeo, et al.
Publicado: (2017)

NAFLD in Some Common Endocrine Diseases: Prevalence, Pathophysiology, and Principles of Diagnosis and Management
por: Lonardo, Amedeo, et al.
Publicado: (2019)

Clinical features and natural history of cryptogenic cirrhosis compared to hepatitis C virus-related cirrhosis
por: Rinaldi, Luca, et al.
Publicado: (2017)

History of Nonalcoholic Fatty Liver Disease
por: Lonardo, Amedeo, et al.
Publicado: (2020)

Can metabolomic signature foster precision medicine approaches in nonalcoholic fatty liver disease arena?
por: Lonardo, Amedeo
Publicado: (2022)

Direct Oral Anticoagulants in Patients with Liver Disease in the Era of Non-Alcoholic Fatty Liver Disease Global Epidemic: A Narrative Review
por: Ballestri, Stefano, et al.
Publicado: (2020)

Gamma glutamyl transferase: A novel cardiovascular outfit for an old liver test
por: Lonardo, Amedeo, et al.
Publicado: (2016)

Nonalcoholic Fatty Liver Disease and Chronic Kidney Disease: Epidemiology, Pathogenesis, and Clinical and Research Implications
por: Lonardo, Amedeo, et al.
Publicado: (2022)

Serum fetuin A level is associated with nonalcoholic fatty liver disease in Chinese population
por: Cui, Zhengsen, et al.
Publicado: (2017)

Fetuin-A Levels Are Increased in Patients With Type 2 Diabetes and Peripheral Arterial Disease
por: Lorant, David Peter, et al.
Publicado: (2011)

Carotid artery endarterectomy in patients with symptomatic non-stenotic carotid artery disease
por: Nardi, Valentina, et al.
Publicado: (2022)

Independent Dose–Response Associations between Fetuin-A and Lean Nonalcoholic Fatty Liver Disease
por: Lu, Chia-Wen, et al.
Publicado: (2021)

Systematic Review and Meta-analysis of Circulating Fetuin-A Levels in Nonalcoholic Fatty Liver Disease
por: Liu, Shousheng, et al.
Publicado: (2021)

The Evolving Role of Fetuin-A in Nonalcoholic Fatty Liver Disease: An Overview from Liver to the Heart
por: Dogru, Teoman, et al.
Publicado: (2021)

Association of Lower Plasma Fetuin-A Levels With Peripheral Arterial Disease in Type 2 Diabetes
por: Eraso, Luis H., et al.
Publicado: (2010)

Glucagon-Like Peptide-1 Receptor Agonists for Treatment of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: An Updated Meta-Analysis of Randomized Controlled Trials
por: Mantovani, Alessandro, et al.
Publicado: (2021)

Fetuin-A, inflammation, and coronary artery calcification in hemodialysis patients
por: Turkmen, K., et al.
Publicado: (2011)

The Relationship of Circulating Fetuin-A With Liver Histology and Biomarkers of Systemic Inflammation in Nondiabetic Subjects with Nonalcoholic Fatty Liver Disease
por: Celebi, Gurkan, et al.
Publicado: (2015)

Intraplaque Enhancement Is Associated With Artery-to-Artery Embolism in Symptomatic Vertebrobasilar Atherosclerotic Diseases
por: Hou, Zhikai, et al.
Publicado: (2021)

Fetuin-A and Fetuin-B in Non-Alcoholic Fatty Liver Disease: A Meta-Analysis and Meta-Regression
por: Pan, Xiongfeng, et al.
Publicado: (2020)

High Fetuin-A Levels in Children with Celiac Disease
por: Kurt, Nezahat, et al.
Publicado: (2022)

Serum Fetuin-A Associated With Fatty Liver Index, Early Indicator of Nonalcoholic Fatty Liver Disease: A Strobe-Compliant Article
por: Huang, Ya, et al.
Publicado: (2015)

Relationship Between Nonalcoholic Fatty Liver Disease Susceptibility Genes and Coronary Artery Disease
por: Brouwers, Martijn C.G.J., et al.
Publicado: (2019)

Association between retinal artery lesions and nonalcoholic fatty liver disease
por: Yang, Wen, et al.
Publicado: (2015)

Which Comes First, Nonalcoholic Fatty Liver Disease or Arterial Hypertension?
por: Golubeva, Julia A., et al.
Publicado: (2023)

Treatment strategies in severe symptomatic carotid and coronary artery disease
por: Dzierwa, Karolina, et al.
Publicado: (2011)

Exercise Training and Revascularization in the Management of Symptomatic Peripheral Artery Disease
por: Biswas, Minakshi P., et al.
Publicado: (2021)

Serum fetuin-A is decreased in cirrhotic patients with Wilson’s disease
por: Vörös, Krisztián, et al.
Publicado: (2023)

Associations of fetuin-A and osteoprotegerin with arterial stiffness and early atherosclerosis in chronic hemodialysis patients
por: Pateinakis, Panagiotis, et al.
Publicado: (2013)

Fetuin, an inhibitor of lymphocyte transformation. The interaction of fetuin with phytomitogens and a possible role for fetuin in fetal development
Publicado: (1975)

Evaluation of the Correlation between Coronary Artery Disease and Nonalcoholic Fatty Liver Disease: Is There Any Correlation?
por: Momayez Sanat, Zahra, et al.
Publicado: (2023)

Association of Lower Extremity Arterial Calcification with Amputation and Mortality in Patients with Symptomatic Peripheral Artery Disease
por: Huang, Chi-Lun, et al.
Publicado: (2014)

Simultaneous hybrid revascularization for symptomatic lower extremity arterial occlusive disease
por: JOH, JIN HYUN, et al.
Publicado: (2014)

Role of Trimetazidine in Ischemic Preconditioning in Patients With Symptomatic Coronary Artery Disease
por: Costa, Leandro M.A., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_o6bbtfd1uj9sksg1fmt0gatk70